Next-Generation Sequencing Data Analysis Market Worth $1.72 Billion By 2028

 Next-generation Sequencing Data Analysis Industry Overview

The global next-generation sequencing data analysis market size was valued at USD 561.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.02% from 2021 to 2028. Next-generation sequencing (NGS) has effectively helped in studying epigenomic as well as genomic patterns associated with various biological processes. However, issues pertaining to storage, management, and accessing information are expected to provide the market with potential R&D opportunities, consequently fueling the growth of the market. Research communities that use high-throughput sequencers demand Laboratory Information Management Systems (LIMSs) for handling and archiving sequencing information. Cloud-based platforms offer favorable solutions for computationally intensive tasks during the analysis of NGS data. Therefore, it has become a quick and easy approach for the acquisition of computational resources to conduct NGS data analysis at a large scale.

The development of cloud-based bioinformatics platforms and services for large-scale NGS data analysis is expected to drive the market at a fast pace. BaseSpace, Bina, DNAnexus, LifeScope, GeneSifter, and SevenBridges are some of the commercially available cloud-based NGS tools readily adopted by end-users to analyze sequencing information.

Gather more insights about the market drivers, restrains and growth of the Global Next-generation Sequencing Data Analysis market

The incorporation of NGS protocols has been specifically used for oncology precision medicine, especially for lung and breast cancers. Companies are also focused on developing low-cost genome sequencing solutions to enhance their businesses. For instance, in October 2021, Phase Genomics announced to launch a cost-effective platform for genome analysis.

Similarly, various stakeholders in the industry are looking for companies that offer low-cost solutions. For instance, Gencoveraised USD 10 million to meet the demand for interpretable and accessible whole-genome sequencing. The company manages the cost by integrating low-pass whole-genome sequencing with a proprietary software-as-a-service computation.

The spontaneous spread of COVID-19 led to the increased emphasis on genome surveillance. Moreover, enhanced capabilities of genome surveillance can support the development of intelligent systems to track virus mutations and variants associated with respiratory conditions. In June 2021, the European Centre for Disease Prevention and Control announced the launch of EpiPulse, a European surveillance portal, for infectious diseases to gather, analyze, and share sequencing data associated with infectious diseases.

Furthermore, the companies are engaged in the deployment of such surveillance platforms, which can provide a robust platform for sequencing and analysis of viruses. For instance, in March 2021, Applied DNA Sciences, Inc. announced the launch of the Linea Genomic Surveillance Mutation Panel for COVID-19 to consolidate the process associated with SARS-CoV-2 variant tracking and detection.

Rising awareness and adoption of such genome surveillance platforms can play a powerful role in handling future health emergencies. In addition, the growth of such platforms is expected to create a lucrative growth opportunity for next-generation sequencing data analysis platforms in the coming years.

 

Browse through Grand View Research's Biotechnology Industry Research Reports.

  • Genotyping Market - The global genotyping market was valued at USD 12.65 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2022 to 2030. The growth can be attributed to technological advancements, the rising prevalence of cancer & genetic disorders, and increasing R&D funding for precision medicine research. Furthermore, the COVID-19 pandemic witnessed a positive impact on the genotyping market, as the pandemic led to an increased demand for COVID-19 genotyping kits. SNP genotyping has been used for the detection of genetic variants of the Covid-19 virus.

 

  • Viral Vectors And Plasmid DNA Manufacturing Market - The global viral vectors and plasmid DNA manufacturing market size was valued at USD 2.87 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.71% from 2022 to 2030. Viral vectors are tools for delivering genetic material into cells. Viruses have developed specific systems for transporting their DNA inside the cells they infect. Furthermore, retrovirus, adenovirus, lentivirus, herpes simplex virus, and others are among the viral vectors which can be employed to transfer genetic material into the genetic composition of cells.

 

Next-generation Sequencing Data Analysis Market Segmentation

Grand View Research has segmented the global next-generation sequencing data analysis market on the basis of product, workflow, mode, read length, end-use, and region:

Next-generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

  • Services
  • NGS Commercial Software

 

Next-generation Sequencing Data Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028)

  • Primary
  • Secondary
  • Tertiary

 

Next-generation Sequencing Data Analysis Mode Outlook (Revenue, USD Million, 2017 - 2028)

  • In-house
  • Outsourced

 

Next-generation Sequencing Data Analysis Read Length Outlook (Revenue, USD Million, 2017 - 2028)

  • Short Read
  • Long Read
  • Very Long Read

 

Next-generation Sequencing Data Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma& Biotech Entities
  • Other Users

 

Next-generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • October 2021: Bionano Genomics, Inc. acquired BioDiscovery, Inc., a software company with the analysis, interpretation, and reporting of genomic data solutions. This acquisition allowed the company to improve its capabilities to analyze and interpret sequencing data. 

 

Key Companies profiled:

Some prominent players in the global Next-generation Sequencing Data Analysis market include

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Illumina, Inc.
  • Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PierianDx
  • Precigen Bioinformatics Germany GmbH
  • Partek Incorporated
  • Eurofins Scientific
  • Pacific Biosciences of California, Inc.
  • DNASTAR, Inc.
  • Congenica Ltd.
  • Fabric Genomics, Inc.
  • Genuity Science
  • DNAnexus Inc.
  • SciGenom Labs Pvt. Ltd.
  • Golden Helix, Inc.
  • Verily Life Science

 

Order a free sample PDF of the Next-generation Sequencing Data Analysis Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more